Garay Arpa insider trades
Garay Arpa has filed 7 Form 4s with the SEC that we hold, for Moderna, Inc. (MRNA) (Chief Commercial Officer) and Merck & Co., Inc. (MRK) (SVP Human Health Global Mktg.). Across all of them we count 0 purchases worth $0 and 3 sales worth $394.4K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 2,290 shares of Moderna, Inc. worth $288.0K, dated 2023-06-06. The first filing on our record is dated 2022-05-03 and the latest 2023-12-07.
Moderna, Inc. (MRNA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-06 | S, sale reported on Form 4 | 2,290 | $288.0K | 2023-06-07 |
| 2023-09-06 | S, sale reported on Form 4 | 574 | $62.2K | 2023-09-07 |
| 2023-12-06 | S, sale reported on Form 4 | 564 | $44.2K | 2023-12-07 |
Merck & Co., Inc. (MRK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1916360) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms